That is necessary, because the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable. To put it simply, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error procedure (jeff brown stock predictions). But now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're designed to do. This was a development nearly no one saw. However it's going to have profound implications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be a lot of financial investment opportunities in this space, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown top biotech 2020). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it drew back maybe substantially before going higher - what is the legacy report predicting. I've been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mainly educating readers. But that's not the big concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So think about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. jeff brown genetic sequencer stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are a lot of fantastic personal business on the brink of striking the public markets And I have actually been working on a brand-new method for you to invest even before these business go public.
This opportunity has been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to schedule your spot totally free.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our usual beat (jeff brown top biotech 2020). And when it comes to tech investing, we leave it to the professionals. The good news is, we have a number of such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing specialists we understand (jeff brown biotech genome sequencing). In truth, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and forecast what's just around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and a lot more. These patterns are experiencing rapid growth and creating extraordinary opportunities for financiers. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. artificial intelligence. But in spite of what numerous readers might think, this is a trend that's just getting going. Even though the COVID-19 pandemic interrupted supply chains last year, an excellent 250 million 5G-enabled devices were still offered.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (biotech stock). Losing two months of production and sales really affects the number of 5G gadgets are offered in the fiscal year. When you consider all of that, selling 250 million systems is remarkable. More importantly, the delays triggered by the pandemic produced a lots of bottled-up demand. And that need is now going to be pressed into 2021. In fact, I predict that more than 500 million 5G devices will be delivered in 2021 - last week. And that's not my only 5G forecast When I've spoken about 5G in the past, I've explained its 3 various stages.
In Stage Two, 5G devices go on sale. 5G phones and other items start to reach customers. And in Stage Three, 5G services start to be offered (brownstone research). That's when we start to see applications running on 5G networks. Think about things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Stage 3 by this summertime. This starts something of a virtuous cycle: The majority of people do not actually care about the innovation. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open a suite of incredible applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The investment chances moving forward will be massive. Stepping far from 5G, the next important technology I visualize in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not work correctly. CRISPR uses a similar concept however with our genetic code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For many years, CRISPR was primarily a specific niche technology that wasn't well understood. And during that time, there were really just three companies running in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating illness and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This entire industry is efficiently a greenfield chance.
There's space for numerous companies to exist in this area. jeff brown biotech genome sequencing. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software can accurately forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is essential due to the fact that the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has been a trial-and-error procedure. Now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug treatments produced utilizing this technology. This was one of those advancements that nearly no one observed. But it's going to have profound implications for treating illness. And, of course, there will be plenty of investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back possibly significantly before going higher. I have actually been covering bitcoin for a long time now. One of the first research reports I ever published was on bitcoin - diplomatic relations. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. But at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. tech predictions. Mass, Mutual is a 150-year-old organization. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date since February 2021, but we might not individually verify this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like capability to select winning innovation stocks. He spent more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an excellent viewpoint on the market. He's constantly on the hunt for new chances, and he shares much of his finest picks in the Near Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully predicted some of the most significant financial occasions of the past 20 years. Although he doesn't appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it best every time, but Jeff Brown's accurate predictions have earned him legions of dedicated fans. That states a lot about his capability. The Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research study uses a number of research services with a wide array of expertises - jeff brown stock predictions.
The company is also associated with Bonner & Partners, another well-respected research publisher - jeff brown biotech picks. On its site, Brownstone states its objective is to provide retail investors with professional-grade research study: "For too long, the very best financial investment research study has actually not been available to specific investors. It has actually been usually booked for financial investment banks, hedge funds, private equity, and high-net-worth clients. first lady. The objective of Brownstone Research is to make that kind of exclusive research readily available to any investors aiming to acquire an edge in the marketplaces. The goal is simple to deliver distinct and rewarding investment research study found no place else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also acts as the firm's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its customers. After decades of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you understand even a little bit about the market, you understand that he has a reputation as a King Midas of sorts. jeff brown 2020 predictions. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown believes S.A.V. jeff brown stock market prediction. might be "the greatest trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding two innovative technologies: expert system and electric automobiles. Musk hopes the mix will help him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing short of the vehicle market's Holy Grail. As you know, electric automobiles and self-driving cars and truck stocks have been substantial this year, however the Wall Street machine has approved buzz without much tangible outcome. Regardless of a drastic increase in competition over the previous few years, Brown still believes Musk has the finest possibility of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Lorry, and it could be the future of transportation. Basically, this technology would enable you to rent your automobile as an autonomous, self-driving taxi when you're not using it. You merely get out of the automobile and press a button on an app that tells the car to "join the fleet." Next thing you know, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a substantial chunk of the profits. It sounds insane, but it might be closed than you think.